Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1

Status

Terminated 3Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gynecologic 5Breast 2Gastrointestinal 1

Conditions

Hereditary Breast and Ovarian Cancer Syndrome 2Uterine Cervical Neoplasms 1Paraneoplastic Syndromes 1Ovarian Neoplasms 1Dermoid Cyst 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Cervical Adenocarcinoma 1Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2384Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1831Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1016Vincristine 964Cetuximab 945Trastuzumab 944Prednisone 941Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Salpingo-oophorectomy × Clear all
NCT01048853 2026-01-07

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer

M.D. Anderson Cancer Center

Phase NA Terminated
137 enrolled 15 charts
Gynecologic

Cervical Adenocarcinoma

NCT02760849 2026-01-07

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

M.D. Anderson Cancer Center

Phase NA Active not recruiting
374 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT06915103 2025-04-08

A Case Report of NMDAR Encephalopathy

Mayo Clinic

Completed
1 enrolled

Dermoid Cyst, Paraneoplastic Syndromes, Anti-N-Methyl-D-Aspartate Receptor Encephalitis

NCT06752135 2024-12-30

HRCC1

Azienda Policlinico Umberto I

Terminated
97 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03382574 2022-06-14

Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Terminated
2 enrolled
Gynecologic

Ovarian Neoplasms

NCT03294343 2017-12-26

Risk-Reducing Surgeries for Hereditary Ovarian Cancer

Peking Union Medical College Hospital

Phase NA Unknown
600 enrolled
BreastGastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡